
GC63402
Rezvilutamide
Also known as 4-[3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
Rezvilutamide (SHR3680) is an androgen receptor antagonist· Rezvilutamide (SHR3680) is used for the study of prostate cancer
ChemicalCAS1572045-62-5MW479.47FormulaC22H20F3N3O4S
- CAS number
- 1572045-62-5
- Molecular weight
- 479.47
- Formula
- C22H20F3N3O4S
- Solubility
- DMSO : 100 mg/mL (208·56 mM; Need ultrasonic)
- InChIKey
- KRBMOYIWQCZVHA-INIZCTEOSA-N
- Catalogue number
- GC63402
- Brand
- GLPBIO
Computed properties PubChem CID 89995232 · XLogP 2.9 · TPSA 129 Ų · H-bond donors 2
- XLogP
- 2.9
- TPSA
- 129 Ų
- H-bond donors
- 2
- H-bond acceptors
- 9
- Rotatable bonds
- 6
- Heavy atoms
- 33
SMILES CC1(C(=O)N(C(=S)N1C2=CC=C(C=C2)OC[C@H](CO)O)C3=CC(=C(C=C3)C#N)C(F)(F)F)C
Computed descriptors from PubChem (CID 89995232), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il